Back to Search
Start Over
Design, production and immunomodulatory potency of a novel allergen bioparticle
- Source :
- PLoS ONE, PLoS ONE, 15(12 December):e0242867. Public Library of Science, PLoS ONE, Vol 15, Iss 12, p e0242867 (2020)
- Publication Year :
- 2020
- Publisher :
- Public Library of Science (PLoS), 2020.
-
Abstract
- Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained efficacy. However, it is poorly developed compared to symptomatic drugs. The main reasons come from treatment duration implying monthly injections during 3 to 5 years or daily sublingual use, and the risk of allergic side-effects. To become a more attractive alternative to lifelong symptomatic drug use, improvements to AIT are needed. Among the most promising new immunotherapy strategies is the use of bioparticles for the presentation of target antigen to the immune system as they can elicit strong T cell and B cell immune responses. Virus-like particles (VLPs) are a specific class of bioparticles in which the structural and immunogenic constituents are from viral origin. However, VLPs are ill-suited for use in AIT as their antigenicity is linked to structure. Recently, synthetic biology has been used to produce artificial modular bioparticles, in which supramolecular assemblies are made of elements from heterogeneous biological sources promoting the design and use of in vivo-assembling enveloped bioparticles for viral and non-viral antigens presentation. We have used a coiled-coil hybrid assembly for the design of an enveloped bioparticle (eBP) that present trimers of the Der p 2 allergen at its surface, This bioparticle was produced as recombinant and in vivo assembled eBPs in plant. This allergen biotherapeutic was used to demonstrate i) the capacity of plants to produce synthetic supramolecular allergen bioparticles, and ii) the immunomodulatory potential of naturally-assembled allergen bioparticles. Our results show that allergens exposed on eBPs induced a very strong IgG response consisting predominantly of IgG2a in favor of the TH1 response. Finally, our results demonstrate that rDer p 2 present on the surface of BPs show a very limited potential to stimulate the basophil degranulation of patient allergic to this allergen which is predictive of a high safety potential.
- Subjects :
- Physiology
medicine.medical_treatment
Cell Membranes
Graduates
medicine.disease_cause
Biochemistry
White Blood Cells
Allergen
Animal Cells
Immune Physiology
Allergies
Medicine and Health Sciences
Immune Response
Mice, Inbred BALB C
Immune System Proteins
Multidisciplinary
Chemistry
Recombinant Proteins
Basophils
medicine.anatomical_structure
Medicine
Educational Status
Female
Immunotherapy
Bronchial Hyperreactivity
Cellular Types
Cellular Structures and Organelles
Bronchoalveolar Lavage Fluid
Research Article
Antigenicity
Allergen immunotherapy
Science
Immune Cells
T cell
Immunology
Alumni
Basophil degranulation
Immunomodulation
Immune system
Antigen
Hypersensitivity
medicine
Animals
Humans
Amino Acid Sequence
Antigens, Dermatophagoides
Antigens
Blood Cells
Biology and Life Sciences
Proteins
Membrane Proteins
DNA
Cell Biology
Allergens
Allergy Immunotherapy
People and Places
Nanoparticles
Immunization
Clinical Immunology
Population Groupings
Clinical Medicine
Protein Processing, Post-Translational
Subjects
Details
- ISSN :
- 19326203
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- PLOS ONE
- Accession number :
- edsair.doi.dedup.....d4a94369b1ab91ea0ed27c7f179bf512